tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

GILDGilead Sciences

Health care · Biotechnology · Nasdaq
Compare with peers → Embed

The biggest changes in the 10-K filed 2026-02-24, this fiscal year against the last, and the sentences in the MD&A (Item 7) where management explains them, quoted word for word. Tickdelta picks sentences that name the line, a direction and a cause. It does not write explanations of its own.

Net income

+1672.9% Big change FY to 2025-12-31 vs 2024-12-31

“Our effective tax rate decreased in 2025, compared to 2024, primarily due to:”

Read it in the 10-K ↗

Operating margin

5.8% → 34.0% (+28.3 pts) Big change FY to 2025-12-31 vs 2024-12-31

“Lower selling, general and administrative expenses; partially offset by”

Read it in the 10-K ↗

Cash from operations

-7.5% FY to 2025-12-31 vs 2024-12-31

“Net cash provided by operating activities decreased in 2025, compared to 2024, primarily due to higher inventory build-up and higher income tax payments, as well as unfavorable timing of accounts receivable collections.”

Read it in the 10-K ↗

Revenue

+2.4% FY to 2025-12-31 vs 2024-12-31

“Total revenues increased 2% to $29.4 billion in 2025, compared to 2024, primarily due to:”

Read it in the 10-K ↗

“HIV product sales increased 6% to $20.8 billion in 2025, compared to 2024, primarily due to higher demand for treatment and prevention, with average realized price being relatively flat despite the U.S.”

Read it in the 10-K ↗

Changes are computed from the XBRL figures in the same 10-K. Hover a number to see the line item. Open the 10-K ↗

Next Accounting checks →

Work on GILD in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/GILD/export.csv") into a cell.